C.E Pharma

Sint-Jans-Molenbeek ·KBO/BCE: BE 0793.409.817

Loading dossier…

Checked · Insight, alerts and connections for every Belgian company, from official sources.

NL FR EN

Product

Search companies Sectors Radar Live Compare Prospects Supplier check Feasibility

Data & registers

Insolvencies Curators Directors Director bans Protection orders Notaries News

Account

Watchlist Portfolio Alerts Pricing

Checked

About Methodology Knowledge base Sources FAQ Help API Badge

Legal

Privacy Terms Contact

Checked AI

Open a company dossier to ask Checked AI about it.

Answers from Checked AI. Not legal advice.

Line item	Code	2023
Balance sheet, Assets
TOTAL ASSETS	20/58	€349k
Fixed assets	21/28	€242k
Intangible fixed assets	21	€121k
Tangible fixed assets	22/27	€121k
Financial fixed assets	28	€111
Current assets	29/58	€107k
Stocks & contracts in progress	3	€33k
Amounts receivable within one year	40/41	€24k
Investments	50/53	€50k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€349k
Equity	10/15	€-6k
Contributions / capital	10/11	€10k
Accumulated profits (losses)	14	€-16k
Amounts payable	17/49	€355k
Amounts payable after one year	17	€247k
Amounts payable within one year	42/48	€109k
Trade debts payable within one year	44	€57k
Income statement
Gross operating margin	9900	€82k
Operating result	9901	€-3k
Financial income	75	€7
Financial charges	65	€13k
Result before taxes	9903	€-16k
Income taxes	67/77	€2
Net result for the period	9904	€-16k
Result to be appropriated	9905	€-16k

Summary